Ignite Creation Date:
2024-05-06 @ 7:42 PM
Last Modification Date:
2024-10-26 @ 3:12 PM
Study NCT ID:
NCT06100939
Status:
RECRUITING
Last Update Posted:
2024-01-24
First Post:
2023-10-20
Brief Title:
Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age with Keratoconus
Sponsor:
Epion Therapeutics
Organization:
Epion Therapeutics
Study Overview
Official Title:
A Multicenter Randomized Double-Masked Sham-Controlled Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age with Keratoconus APRICITY-A
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Apricity-A
Brief Summary:
A Multicenter Randomized Double-Masked Sham-Controlled Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
True
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None